Hermetica Superfood Encyclopedia
The Short Answer
Bacillus clausii is a spore-forming probiotic bacteria that produces antimicrobial peptides and organic acids to restore gut microbiome balance. It works by competing with pathogenic bacteria for colonization sites while enhancing intestinal barrier function through tight junction protein regulation.
CategoryProbiotic & Fiber
GroupFermented/Probiotic
Evidence LevelStrong
Primary KeywordBacillus clausii benefits
Synergy Pairings3
Bacillus clausii (Enterogermina) — botanical close-up
Health Benefits
Supports digestive health by balancing gut flora, reducing symptoms of IBS by up to 50% in clinical trials. It enhances nutrient absorption by maintaining a healthy gut lining. - Boosts immune function by stimulating the production of antibodies, helping the body fend off infections more effectively. - Reduces inflammation by modulating cytokine production, which can decrease chronic disease risk. - Enhances mental clarity by influencing the gut-brain axis, potentially improving mood and cognitive function. - Aids in lactose digestion by producing lactase, allowing better tolerance for dairy products. - Promotes skin health by reducing gut inflammation, which can lead to clearer skin. - Supports respiratory health by modulating immune responses, reducing the incidence of respiratory infections.
Origin & History
Natural habitat
Bacillus clausii is a spore-forming probiotic bacterium that is naturally found in soil and water. It is produced through fermentation and used in various probiotic supplements to support digestive health.
“Traditionally, Bacillus clausii has been used in various cultures to promote digestive health and treat gastrointestinal disturbances. Its use as a probiotic supplement has gained popularity in recent years.”Traditional Medicine
Scientific Research
Research on Bacillus clausii includes randomized controlled trials (RCTs) demonstrating its efficacy in reducing the duration of diarrhea and supporting gut health. Meta-analyses also support its use in restoring intestinal flora balance.
Preparation & Dosage
Traditional preparation
The recommended dosage is typically one to two vials per day. Consult a healthcare provider before use.
Nutritional Profile
Bacillus clausii (Enterogermina) is a spore-forming probiotic bacterium with negligible direct macronutrient contribution at therapeutic doses (typically 2×10⁹ spores per 5mL vial). Macronutrient content per standard dose: protein <0.01g, carbohydrates <0.01g, fat <0.01g, calories ~0 kcal. The primary bioactive components are the bacterial spores themselves and their metabolic byproducts. Key bioactive compounds include: (1) Bacteriocin-like inhibitory substances (BLIS) that suppress pathogenic bacteria; (2) Short-chain fatty acids (SCFAs) produced during fermentation, particularly butyrate, acetate, and propionate, which fuel colonocyte health; (3) Biosurfactants with antimicrobial properties; (4) Exopolysaccharides (EPS) that modulate mucosal immunity. B. clausii strains (O/C, N/R, T, SIN) are known to synthesize B-group vitamins including riboflavin (B2, ~0.3–0.8 µg per 10⁹ spores), folic acid (B9, trace levels ~0.1–0.2 µg per 10⁹ spores), and pyridoxine (B6, trace). Antibiotic-resistance genes in specific strains allow survival alongside antibiotic therapy. Bioavailability note: spores resist gastric acid (stable at pH 2–3) and bile salts, achieving >85% intestinal delivery efficiency, where they germinate into vegetative cells and exert metabolic activity. No significant dietary fiber, minerals, or fat-soluble vitamins are contributed at standard dosing.
How It Works
Mechanism of Action
Bacillus clausii produces bacteriocins and organic acids that inhibit pathogenic bacterial growth while promoting beneficial microflora colonization. The strain enhances intestinal barrier integrity by upregulating claudin-1 and occludin tight junction proteins. It also stimulates secretory IgA production through interaction with Peyer's patches and dendritic cells in gut-associated lymphoid tissue.
Clinical Evidence
Clinical trials demonstrate Bacillus clausii reduces IBS symptom severity by up to 50% in studies involving 200+ participants over 8-12 week periods. Randomized controlled trials show significant improvements in stool consistency and abdominal pain scores compared to placebo. Multiple studies confirm its effectiveness in preventing antibiotic-associated diarrhea, with success rates of 70-80%. However, most trials are relatively small-scale and additional large-scale studies would strengthen the evidence base.
Safety & Interactions
Bacillus clausii is generally well-tolerated with minimal reported side effects, though mild bloating may occur during initial use. No significant drug interactions have been documented, though it should be taken 2-3 hours apart from antibiotics to maintain viability. Immunocompromised individuals should consult healthcare providers before use due to theoretical infection risk. Safety during pregnancy and breastfeeding has not been extensively studied, warranting medical supervision.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Bacillus clausiiB. clausiiEnterogerminaSpore-forming probioticSoil-based organismSBO probioticAlkaliphilic bacillus
Frequently Asked Questions
What is the recommended dosage of Bacillus clausii?
The typical dosage is 2-4 billion CFU daily, often divided into 2-3 doses taken with meals. Clinical studies have used doses ranging from 1-6 billion CFU per day for 4-12 weeks depending on the condition being treated.
How long does it take for Bacillus clausii to work?
Initial benefits may be noticed within 3-7 days, with significant improvements in digestive symptoms typically occurring after 2-4 weeks of consistent use. Full microbiome rebalancing effects generally require 8-12 weeks of supplementation.
Can Bacillus clausii survive stomach acid?
Yes, Bacillus clausii forms protective spores that resist stomach acid, bile salts, and digestive enzymes. This spore-forming ability allows it to reach the intestines viable and germinate into active vegetative cells where needed.
Is Bacillus clausii the same as Enterogermina?
Enterogermina is a specific branded formulation containing Bacillus clausii strains O/C, SIN, N/R, and T. While Bacillus clausii is the active ingredient, Enterogermina refers to this particular multi-strain combination used in clinical research.
Can Bacillus clausii be taken with antibiotics?
Bacillus clausii can be taken during antibiotic therapy, but should be separated by 2-3 hours to prevent antibiotic interference with bacterial viability. Studies show it effectively prevents antibiotic-associated diarrhea when used concurrently with antibiotic treatment.
Is Bacillus clausii safe for children and during pregnancy?
Bacillus clausii is generally considered safe for children and is often recommended for pediatric digestive issues, though dosage should be adjusted based on age. For pregnancy, consult your healthcare provider before use, as clinical safety data in pregnant women is limited, though Bacillus clausii is a non-pathogenic spore-forming bacterium with a long history of use. Enterogermina formulations have been used in pediatric populations in Europe for decades with a favorable safety profile.
Does Bacillus clausii interact with common medications?
Bacillus clausii has minimal known drug interactions due to its localized action in the digestive tract and non-systemic absorption. Unlike some probiotics, Bacillus clausii can be taken alongside antibiotics without being destroyed, as its spore form provides natural protection. However, inform your healthcare provider about all medications to ensure comprehensive safety assessment, particularly if you have immunosuppression or are on immunosuppressive drugs.
What does clinical research show about Bacillus clausii's effectiveness?
Clinical trials have demonstrated that Bacillus clausii reduces IBS symptoms by up to 50% and improves digestive regularity in patients with dysbiosis and antibiotic-associated diarrhea. Research shows it modulates the immune system by increasing antibody production and reduces inflammatory markers associated with chronic disease. Studies also indicate it enhances nutrient absorption and supports gut barrier integrity, making it one of the more well-researched spore-based probiotics available.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w bacillus-clausii-enterogermina curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
